Krina K. Patel
0000-0002-8894-027X
Publication & Citation Trends
Publications
0 total
Genomics Define Neoplastic Transformation in Multiple Myeloma Precursor Conditions
Cited by 0
Semantic Scholar
Racial and Ethnic Differences in Outcomes of Multiple Myeloma Patients Treated with Teclistamab
Cited by 0
Semantic Scholar
Monosomy 13 and Deletion of 13q Predict Inferior Outcomes in Multiple Myeloma Patients Undergoing Upfront Autologous Transplant
Cited by 0
Semantic Scholar
Trial in Progress: QUINTESSENTIAL—A Phase 2 Study of Arlocabtagene Autoleucel (arlo-cel) in Triple- and Quad-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma (RRMM)
Cited by 0
Semantic Scholar
Treatment-Free Hospitalization-Free Time With CAR T-Cell Therapy Versus Standard Regimens and Quality of Life Implications in Patients With Relapsed/Refractory MM: Findings From the KarMMa-3 Trial
Cited by 0
Semantic Scholar
Infections in Patients (Pts) with Multiple Myeloma (Mm) Treated with BCMA-Directed CAR T Cell Therapies and Bispecific Antibodies: Analysis of the FDA Adverse Event Reporting System (FAERS)
Cited by 0
Semantic Scholar
Phase 2 Registrational Study of Anitocabtagene Autoleucel for Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results from iMMagine-1
Cited by 1
Semantic Scholar
Outcomes of Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant Following VRD or KRD Induction Therapy
Cited by 0
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(369)
CAR-T cell therapy research
(153)
Protein Degradation and Inhibitors
(103)
Chronic Lymphocytic Leukemia Research
(55)
Cancer Treatment and Pharmacology
(53)
Affiliations
Rutgers, The State University of New Jersey
University of Vermont
Dartmouth–Hitchcock Medical Center
Joslin Diabetes Center
The University of Texas MD Anderson Cancer Center